{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:01:48Z","timestamp":1770469308717,"version":"3.49.0"},"reference-count":30,"publisher":"Index Copernicus","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngol Pol"],"published-print":{"date-parts":[[2025,2,26]]},"abstract":"<jats:p>&lt;b&gt;Introduction:&lt;\/b&gt; Severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) are frequently comorbid diseases caused by type 2 inflammation. The complete etiology of these forms still remains unexplained, which makes causal and fully effective therapeutic management impossible. New therapeutic options using the knowledge of Th2 inflammatory endotype are based on anti-IL5 (mepolizumab, reslizumab), anti-IL5R (benralizumab), anti-IgE (omalizumab), and anti-IL4\/IL13 (dupilumab) monoclonal antibodies. Recently, biological therapy has provided a new personalized therapeutic option for patients with CRSw NP. &lt;br&gt;&lt;br&gt;&lt;b&gt;Aim:&lt;\/b&gt; The aim of the study was to evaluate the efficacy of mepolizumab, benralizumab, omalizumab, and dupilumab in the reduction of rhinological symptoms in severe asthmatic patients with chronic rhinosinusitis with nasal polyps. &lt;br&gt;&lt;br&gt;&lt;b&gt;Materials and methods:&lt;\/b&gt; In 32 (9 male, 18%) patients with CRSwNP and severe bronchial asthma treated with biologics \u2013 mepolizumab (19, 59%), omalizumab (5, 15%), benralizumab (6, 19%), and dupilumab (2, 6%) for 6 months, a subjective evaluation of rhinologic symptoms was conducted (TNSS, SNOT, smell evaluation). &lt;br&gt;&lt;br&gt;&lt;b&gt;Results:&lt;\/b&gt; In all analyzed groups, 6-month treatment with mepolizumab, omalizumab, and benralizumab resulted in significant improvement in rhinitis symptoms assessed by TNSS and SNOT scales as well as in the sense of smell. Due to the small group of patients treated with dupilumab, statistical analysis in this group was not performed. &lt;br&gt;&lt;br&gt;&lt;b&gt;Conclusions:&lt;\/b&gt; Our real-life observation confirmed that biological therapy based on phenotyping enables achieving optimal therapeutic effects for patients with CRSwNP and severe bronchial asthma. Biological therapy should be conducted through a collaborative and multidisciplinary approach.<\/jats:p>","DOI":"10.5604\/01.3001.0054.9674","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:34:23Z","timestamp":1740566063000},"page":"1-7","source":"Crossref","is-referenced-by-count":4,"title":["Results of personalized biological therapy in patients with chronic rhinosinusitis with nasal polyps and severe uncontrolled bronchial asthma \u2013 real-life study"],"prefix":"10.5604","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8160-1948","authenticated-orcid":false,"given":"Edyta","family":"Jura-Szoltys","sequence":"first","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of  Silesia, Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-4048","authenticated-orcid":false,"given":"Aleksandra","family":"Niemiec-Gorska","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of  Silesia, Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6339-9053","authenticated-orcid":false,"given":"Joanna","family":"Gl\u0215ck","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of  Silesia, Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesia","family":"Rozlucka","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of  Silesia, Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-8923","authenticated-orcid":false,"given":"Olga","family":"Branicka","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of  Silesia, Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9653-0801","authenticated-orcid":false,"given":"Barbara","family":"Rymarczyk","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of  Silesia, Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-9165","authenticated-orcid":false,"given":"Radoslaw","family":"Gawlik","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of  Silesia, Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","reference":[{"key":"627120r1","doi-asserted-by":"crossref","unstructured":"Tran T.N., Zeiger R.S., Peters S.P. et al.: Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma. Ann Allergy Asthma Immunol., 2016; 116(1): 37\u201342.","DOI":"10.1016\/j.anai.2015.10.027"},{"key":"627120r2","doi-asserted-by":"crossref","unstructured":"Castillo Vizuete J.A., Sastre J., Del Cuvillo Bernal A. et al.: Asthma, rhinitis, and nasal polyp multimorbidities. Arch Bronconeumol (Engl Ed)., 2019; 55(3):146\u2013155.","DOI":"10.1016\/j.arbr.2018.12.020"},{"key":"627120r3","doi-asserted-by":"crossref","unstructured":"Kato A., Peters A.T., Stevens W.W. et al.: Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy., 2022; 77(3): 812\u2013826.","DOI":"10.1111\/all.15074"},{"key":"627120r4","doi-asserted-by":"crossref","unstructured":"Alobid I., Bernal-Sprekelsen M., Mullol J. et al.: Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life. Allergy., 2008; 63(10): 1267\u20131279.","DOI":"10.1111\/j.1398-9995.2008.01828.x"},{"key":"627120r5","doi-asserted-by":"crossref","unstructured":"Mullol J., Azar A., Buchheit K.M. et al.: Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era. J Allergy Clin Immunol Pract., 2022; 10(6): 1434\u20131453.","DOI":"10.1016\/j.jaip.2022.03.002"},{"key":"627120r6","unstructured":"Fokkens W.J., Lund V.J., Hopkins C. et al.: European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology., 2020; 58(Suppl S29): 1\u2013464."},{"key":"627120r7","unstructured":"Hellings P.W., Fokkens W.J., Orlandi R.et al.: The EUFOREA pocket guide for chronic rhinosinusitis. Rhinology., 2023; 61(1): 85\u201389."},{"key":"627120r8","doi-asserted-by":"crossref","unstructured":"De Corso E., Bil\u00f2 M.B., Matucci A. et al.: Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement. J Pers Med., 2022; 12(5): 846.","DOI":"10.3390\/jpm12050846"},{"key":"627120r9","doi-asserted-by":"crossref","unstructured":"Fokkens W.J., Viskens A.S., Backer V. et al.: EPOS\/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology., 2023; 61(3): 194\u2013202.","DOI":"10.4193\/Rhin22.489"},{"key":"627120r10","unstructured":"Haxel B.R., Hummel T., Fruth K. et al.: Real-world-effectiveness of biological treatment for severe chronic rhinosinusitis with nasal polyps. Rhinology., 2022; 60(6): 435\u2013443."},{"key":"627120r11","doi-asserted-by":"crossref","unstructured":"Jurkiewicz D., Kupczyk M., Bro\u017cek-M\u0105dry E. et al.: Biologicals in the treatment of chronic rhinosinusitis with nasal polyps \u2013 position of the Polish Society of Otorhinolaryngologists \u2013Head and Neck Surgeons and the Polish Society of Allergology experts. Otolaryngol Pol., 2023; 77(2): 1\u201311.","DOI":"10.5604\/01.3001.0053.5965"},{"key":"627120r12","doi-asserted-by":"crossref","unstructured":"Bachert C., Zhang N., Holtappels G. et al.: Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol., 2010; 126(5): 962\u2013968.","DOI":"10.1016\/j.jaci.2010.07.007"},{"key":"627120r13","unstructured":"Za\u0142\u0105cznik B.44. LECZENIE CHORYCH Z CI\u0118\u017bK\u0104 POSTACI\u0104 ASTMY (ICD-10: J45, J82). https:\/\/www.gov.pl\/attachment\/0ca7e3df-f174-41ba-9930-3c0260a704aa (10.11.2024)."},{"key":"627120r14","doi-asserted-by":"crossref","unstructured":"Boulet L.P., Reddel H.K., Bateman E. et al.: The Global Initiative for Asthma (GINA): 25 years later. Eur Respir J., 2019; 54(2): 1900598.","DOI":"10.1183\/13993003.00598-2019"},{"key":"627120r15","doi-asserted-by":"crossref","unstructured":"Bernstein I.L., Li J.T., Bernstein D.I. et al.: Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol., 2008; 100(3): S1\u2013S148.","DOI":"10.1016\/S1081-1206(10)60305-5"},{"key":"627120r16","doi-asserted-by":"crossref","unstructured":"Laidlaw T.M., Mullol J., Woessner K.M.: et al.: Chronic Rhinosinusitis with Nasal Polyps and Asthma. J Allergy Clin Immunol Pract., 2021; 9(3): 1133\u20131141.","DOI":"10.1016\/j.jaip.2020.09.063"},{"key":"627120r17","doi-asserted-by":"crossref","unstructured":"Mora T., S\u00e1nchez-Collado I., Mu\u00f1oz-Cano R. et al.: Prevalence and coexistence of type 2 inflammatory diseases. Clin Transl Allergy., 2024; 14(6): e12376.","DOI":"10.1002\/clt2.12376"},{"key":"627120r18","doi-asserted-by":"crossref","unstructured":"Kim D.K., Lee B.C., Park K.J. et al: Effect of Obstructive Sleep Apnea on Immunity in Cases of Chronic Rhinosinusitis With Nasal Polyps. Clin Exp Otorhinolaryngol., 2021; 14(4): 390\u2013398.","DOI":"10.21053\/ceo.2020.02250"},{"key":"627120r19","doi-asserted-by":"crossref","unstructured":"Bhatti M.T. : Neuro-ophthalmic complications of endoscopic sinus surgery. Curr Opin Ophthalmol., 2007; 18(6): 450\u2013458.","DOI":"10.1097\/ICU.0b013e3282f0b47e"},{"key":"627120r20","doi-asserted-by":"crossref","unstructured":"Stankiewicz J.A., Lal D., Connor M. et al.: Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25-year experience. Laryngoscope., 2011; 121(12): 2684\u20132701.","DOI":"10.1002\/lary.21446"},{"key":"627120r21","doi-asserted-by":"crossref","unstructured":"Chapurin N., Wu J., Labby A.B. et al.: Current insight into treatment of chronic rhinosinusitis: Phenotypes, endotypes, and implications for targeted therapeutics. J Allergy Clin Immunol., 2022; 150(1): 22\u201332.","DOI":"10.1016\/j.jaci.2022.04.013"},{"key":"627120r22","doi-asserted-by":"crossref","unstructured":"Bal C., Stoshikj S., Milger K. et al: German asthma net: Nasal polyposis in patients in the severe asthma registry. Allergy., 2024; 79: 3133\u20133138.","DOI":"10.1111\/all.16186"},{"key":"627120r23","doi-asserted-by":"crossref","unstructured":"Papacharalampous G.X., Constantinidis J., Fotiadis G. et al.: Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy. Int Forum Allergy Rhinol., 2024; 14(1): 96\u2013109.","DOI":"10.1002\/alr.23234"},{"key":"627120r24","doi-asserted-by":"crossref","unstructured":"Husain Q., Hoehle L., Phillips K. et al: The 22-Item Sinonasal Outcome Test as a Tool for the Assessment of Quality of Life and Symptom Control in Allergic Rhinitis. Am J Rhinol Allergy., 2020; 34(2): 209\u2013216.","DOI":"10.1177\/1945892419884789"},{"key":"627120r25","doi-asserted-by":"crossref","unstructured":"Downie S.R., Andersson M., Rimmer J. et al.: Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite-sensitive subjects: Allergy., 2004; 59(4): 406\u2013414.","DOI":"10.1111\/j.1398-9995.2003.00420.x"},{"key":"627120r26","unstructured":"Rapiejko P.: Zmys\u0142 w\u0119chu. Allergoprofil., 2006; 4(7): 4\u201310."},{"key":"627120r27","doi-asserted-by":"crossref","unstructured":"Barroso B., Valverde-Monge M., Betancor D. et al: Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review. J Investig Allergol Clin Immunol., 2023; 33(6): 419\u2013430.","DOI":"10.18176\/jiaci.0939"},{"key":"627120r28","doi-asserted-by":"crossref","unstructured":"Rubel K.E., Lubner R.J., Lopez A.A. et al.: Inflammatory characteristics of central compartment atopic disease. Int Forum Allergy Rhinol., 2023; 13(12): 2133\u20132143.","DOI":"10.1002\/alr.23207"},{"key":"627120r29","doi-asserted-by":"crossref","unstructured":"Bachert C., Han J.K., Desrosiers M. et al: Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet., 2019; 394(10209): 1638\u20131650.","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"627120r30","doi-asserted-by":"crossref","unstructured":"Cottin S., Doyen V., Pilette C.: Upper airway disease diagnosis as a predictive biomarker of therapeutic response to biologics in severe asthma. Front Med (Lausanne)., 2023; 22(10): 1129300.","DOI":"10.3389\/fmed.2023.1129300"}],"container-title":["Otolaryngologia Polska"],"original-title":[],"link":[{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0054.9674","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0054.9674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:56:42Z","timestamp":1742201802000},"score":1,"resource":{"primary":{"URL":"https:\/\/otolaryngologypl.com\/gicid\/01.3001.0054.9674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,20]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0054.9674","relation":{},"ISSN":["0030-6657","2300-8423"],"issn-type":[{"value":"0030-6657","type":"print"},{"value":"2300-8423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}